​

Funding Round

Series A - Syndax Pharmaceuticals

Series A - Syndax Pharmaceuticals

Investment Firm

Overview

Syndax Pharmaceuticals focuses on developing an HDAC inhibitor for solid tumors and hematological tumors.

Announced Date

Apr 03, 2007

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Domain Associates

Domain Associates

Domain Associates is a early_stage_venture and late_stage_venture and private_equity firm.

MPM Capital

MPM Capital

MPM Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

5

Investor Name
Participant InvestorForward Ventures
Participant InvestorMPM Capital
Participant InvestorPappas Ventures
Participant InvestorDomain Associates
Participant InvestorAvalon Ventures

Round Details and Background

Syndax Pharmaceuticals raised $40000000 on 2007-04-03 in Series A

Syndax Pharmaceuticals focuses on developing an HDAC inhibitor for solid tumors and hematological tumors.

Company Funding History

15

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 13, 2014
Venture Round - Syndax Pharmaceuticals
-1.7M
Apr 05, 2010
Debt Financing - Syndax Pharmaceuticals
-6.0M
Aug 27, 2013
Series B - Syndax Pharmaceuticals
4-26.6M
Mar 16, 2010
Series A - Syndax Pharmaceuticals
5-9.0M

Recent Activity

There is no recent news or activity for this profile.